Malaria

Fans of two distinct soccer clubs join forces for an anti-government protest in Sao Paulo, Brazil, Sunday, May 31, 2020. Police used tear gas to disperse anti-government protesters in Brazil's largest city as they began to clash with small groups loyal to President Jair Bolsonaro. (AP Photo/Andre Penner)
May 31, 2020 - 3:49 pm
WASHINGTON (AP) — The U.S. has sent to Brazil more than 2 million doses of a malaria drug touted by President Donald Trump as potentially protecting against and treating the coronavirus, even though scientific evidence has not backed up those uses. No large, rigorous scientific studies have found...
Read More
FILE - In this Tuesday, May 19, 2020 file photo, a chemist holds a pack of hydroxychloroquine tablets in Mumbai, India. A Friday, May 22, 2029 report in the journal Lancet shows malaria drugs pushed by U.S. President Donald Trump as treatments for the coronavirus not only did not help but were tied to a greater risk of death and heart rhythm problems in a study of nearly 100,000 patients around the world. (AP Photo/Rafiq Maqbool)
May 22, 2020 - 4:04 pm
Malaria drugs pushed by President Donald Trump as treatments for the coronavirus did not help and were tied to a greater risk of death and heart rhythm problems in a new study of nearly 100,000 patients around the world. Friday’s report in the journal Lancet is not a rigorous test of...
Read More
President Donald Trump speaks during an event on the food supply chain amid the coronavirus pandemic, in the Roosevelt Room of the White House, Tuesday, May 19, 2020, in Washington. (AP Photo/Evan Vucci)
May 19, 2020 - 9:08 pm
WASHINGTON (AP) — President Donald Trump emphatically defended himself Tuesday against criticism from medical experts that his announced use of a malaria drug against the coronavirus could spark wide misuse by Americans of the unproven treatment with potentially fatal side effects. Trump's...
Read More
A chemist displays hydroxychloroquine tablets in Mumbai, India, Tuesday, May 19, 2020. President Donald Trump’s declaration that he was taking the antimalarial drug of dubious effectiveness to help fend off the coronavirus will be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring the world’s largest producer of the drug to make much more of it, prescribe it for front-line health workers treating cases of the coronavirus and deploy it as a diplomatic tool, despite mounting evidence against using the drug for COVID-19. (AP Photo/Rafiq Maqbool)
May 19, 2020 - 5:50 pm
NEW DELHI (AP) — President Donald Trump’s declaration that he was taking a malaria drug of dubious effectiveness to help fend off the coronavirus will likely be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring...
Read More
President Donald Trump speaks during an event on the food supply chain amid the coronavirus pandemic, in the Roosevelt Room of the White House, Tuesday, May 19, 2020, in Washington. (AP Photo/Evan Vucci)
AP News
May 19, 2020 - 4:53 pm
WASHINGTON (AP) — President Donald Trump emphatically defended himself Tuesday against criticism from medical experts that his announced use of a malaria drug against the coronavirus could spark wide misuse by Americans of the unproven treatment with potentially fatal side effects. Trump's...
Read More
President Donald Trump tells reporters that he is taking zinc and hydroxychloroquine during a meeting with restaurant industry executives about the coronavirus response, in the State Dining Room of the White House, Monday, May 18, 2020, in Washington. (AP Photo/Evan Vucci)
AP News
May 18, 2020 - 4:29 pm
WASHINGTON (AP) — President Donald Trump said Monday that he is taking a malaria drug to protect against the new coronavirus, despite warnings from his own government that it should only be administered for COVID-19 in a hospital or research setting due to potentially fatal side effects. Trump told...
Read More
Veterans Affairs Secretary Robert Wilkie speaks about protecting seniors, in the East Room of the White House, Thursday, April 30, 2020, in Washington. (AP Photo/Alex Brandon)
May 15, 2020 - 9:14 pm
WASHINGTON (AP) — Facing growing criticism, the Department of Veterans Affairs said Friday that it will not halt use of an unproven malaria drug on veterans with COVID-19 but that fewer of its patients are now taking it. In responses provided to Congress and obtained by The Associated Press, the VA...
Read More
Veterans Affairs Secretary Robert Wilkie talks before President Donald Trump arrives to speak about protecting seniors, in the East Room of the White House, Thursday, April 30, 2020, in Washington. (AP Photo/Alex Brandon)
May 10, 2020 - 6:15 am
WASHINGTON (AP) — The Senate’s top Democrat on Sunday called on the Department of Veterans Affairs to explain why it allowed the use of an unproven drug on veterans for the coronavirus, saying patients may have been put at unnecessary risk. Sen. Charles Schumer of New York said the VA needs to...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine tablets in Las Vegas. According to results released on Thursday, May 7, 2020, a new study finds no evidence of benefit from a malaria drug widely promoted as a treatment for coronavirus infection. Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 consecutive patients treated at Columbia University Irving Medical Center in New York. (AP Photo/John Locher)
May 07, 2020 - 2:17 pm
A new study finds no evidence of benefit from a malaria drug widely promoted as a treatment for coronavirus infection. Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 patients treated at Columbia University in New York,...
Read More
In this image provided by Public Health Emergency, a department of Health and Human Services, Rick Bright is shown in his official photo from April 27, 2017, in Washington. Bright filed a complaint May 5, 2020, with the Office of Special Counsel, a government agency responsible for whistleblower complaints. He’s the former director of the Biomedical Advanced Research and Development Authority. Bright alleges he was removed from his job and reassigned to a lesser role because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug favored by President Donald Trump. (Health and Human Services via AP)
May 05, 2020 - 3:15 pm
WASHINGTON (AP) — The Trump administration failed to prepare for the onslaught of the coronavirus, then sought a quick fix by trying to rush an unproven drug to patients, a senior government scientist alleged in a whistleblower complaint Tuesday. Dr. Rick Bright, former director of the Biomedical...
Read More

Pages